Philips IQon Elite Spectral CT Scanner with Unique Dual Energy Detector

Philips has launched a completely new true spectral CT scanner, the IQon Elite Spectral CT. Spectral CT supplies a more nuanced take a look at body tissues, which reveals some good info concerning the composition of anatomy and not just its structure. The various frequencies of X-sun rays inside a spectral CT could be when compared with different colors of sunshine, that are created by different frequencies of visible radiation. Inside a spectral CT, such things as iodine go to lower powers, as the visual impact of metal could be reduced when viewing the greater energy data.

The brand new device, coded in a partnership with radiologists at Hadassah Hebrew College Clinic in Jerusalem, Israel, has a dual energy “NanoPanel” prism detector by having an efficient yttrium-based scintillator. We’ve got the technology has the capacity to separate the various energy X-sun rays released concurrently with a single tube source. This enables for concurrent generation of conventional and spectral CT images which are perfectly aligned with one another. To compare, other spectral CTs alternate emitting X-sun rays at different powers, that also leads to getting to select of whether or not to use conventional or spectral prior to starting a test.

Using the IQon Elite Spectral CT, every scan is both a spectral and traditional scan and also the imaging from both can be obtained following a test. Forget about radiation can be used compared to a standard comparable scan and also the workflow doesn’t change either, making the development of we’ve got the technology easy around the staff.

Publish exam software enables radiologists to evaluate the traditional CT images after which, as necessary, to slip through different levels of energy, from 40 to 200 keV, to see exactly the same anatomy inside a “different light”. In addition, there’s a “magic glass” feature that enables the radiologist to maneuver a button across an area so the degree of energy round the mouse reaches one number while everything around it’s at another, assisting to place details that could well be missed.

Here’s a relevant video from Philips explaining how its spectral CT technology works:

Here’s a hyperlink to Philips’ spectral CT info page…

More from Philips…

Seno Medical’s Imagio Combines Optoacoustics with Ultrasound to Identify Cancer Of The Breast

Finally week’s RSNA conference in Chicago, we’ve got an opportunity to find out about Seno Medical Instruments, a Dallas, Texas company, and its imaging technology that mixes conventional ultrasound with a brand new modality known as optoacoustic imaging. We spoken with Dr. Tom Stavros, Medical Director at Seno.

Their Imagio system uses duplex probe that appears and functions just like a regular ultrasound transducer, however that also emits laser light to concurrently act as an optoacoustic imaging device. In optoacoustics, laser light can be used to include energy to tissue, that is then released by means of ultrasound waves. These waves could be detected, but unlike conventional ultrasound, they contain details about bloodstream and it is oxygenation. Ultrasound is fairly proficient at seeing the structures of tissues, as well as in this product, optoacoustics offers the functional look at bloodstream oxygenation and increases the contrast, that make it crucial for recognizing tumors, as tumors consume much more oxygen than nearby tissues.

The Imagio product is meant for cancer of the breast diagnostics instead of screening, and people are envisioned having been screened using ultrasound prior to being imaged by Seno’s system. Roughly 80% of breast biopsies come out negative nowadays, a disturbingly large number, so almost anything to improve this would be highly advantageous for reducing costs, increasing the emotional wellness of patients, and becoming the best people faster from screening to treatment. To that particular effect, medical trial data just been released at RSNA that implies that the Imagio can help to eliminate false positives breast exams and benign biopsies.

The machine images at 30 fps using ultrasound and also at 10 fps via optoacoustics. The optoacoustic component depends on shining two wavelengths (lengthy and short) of sunshine sequentially. The lengthy wave length is absorbed by oxygenated bloodstream, as the shorter the first is more readily absorbed by deoxygenated bloodstream, supplying a look at both along with a contrast between parts of different oxygenation.

We examined a lot of pictures of scans done by the Imagio, that have red colorization showing deoxygenated bloodstream and eco-friendly color highlighting oxygenated regions. The pictures are produced by sweeping the Imagio probe over the lesion, together with a couple of centimeters round the lesion. By comprehending the morphology from the vasculature that feeds a tumor and just how it consumes oxygen, it’s possible to identify tumors in some instances while ruling them in others with very good precision.

This really is partly because unlike ultrasound, optoacoustics enables a distinctive view in the area surrounding the tumor where many of the signature angiogenesis takes place that suggests the presence of the encompassing tumor. Particularly, oxygen being metabolized in specific ways differentiates a suspected lesion from a benign tissue along with a cancerous tumor that requires treatment. Furthermore, the orientation from the vessels prior to a lesion may also indicate whether it’s most likely cancerous or benign.

It will appear enjoy it will need a large amount of training to be able to perfect how one interprets the pictures that Seno Medical’s system produces. Nonetheless, having the ability to avoid unnecessary biopsies, which number within the millions each year, will be a major win for breast care generally. Seno continues to have to convince the Food and drug administration that it is Imagio system merits being removed to be used used within the U . s . States.

Here’s a relevant video from Seno Medical explaining how optoacoustics works:

Link: Seno Medical…

Related announcement: Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio™ Opto-Acoustic Breast Imaging System in lessening False Positive Breast Examinations and Benign Biopsies…

RICOH Megabites Magnetoencephalography System Wins Food and drug administration Clearance


Ricoh, a sizable Japanese industrial company, won Food and drug administration clearance because of its RICOH MEG magnetoencephalography  system. The unit has the capacity to identify electrical signals inside the brain by calculating the magnetic fields created as electric currents move inside the brain.

Based on the organization, the unit was created to supply “deeper measurement (hippocampus and hypothalamus), clearer signal using coaxial gradiometer sensors and greater patient comfort for much better data acquisition.”

The machine was really produced by Yokogawa Electric, a Japanese firm, however the medical division of this company was offered to Ricoh in 2016.

Via: RICOH…

Editors

At Medgadget, we set of the most recent medical technology news, interview leaders within the field, and file dispatches from medical occasions from around the globe.

Ultrasound Imaging Needle Set to change Heart Surgery

Researchers working in london have printed information on an innovative new cardiology needle able to imaging the heart’s soft tissues from inside. They from College College London (UCL) and Queen Mary College based in london (QMUL) used the brand new all-optical ultrasound imaging system for heart surgery in pigs, effectively recording high-resolution images as much as 2.5cm from the needle tip.

An exciting-optical ultrasound device may seem as an oxymoron, however the imaging needle depends on an embedded miniature optical fiber that transmits brief pulses of sunshine, which generate ultrasound pulses. These ultrasound pulses propagate from the needle, reflecting off soft tissues prior to being detected with a second optical fiber within the needle housing.

The very first time live imaging is now able to taken directly from the heart during keyhole surgery, which can offer vast enhancements over current practice, where surgeons depend on preoperative imaging coupled with exterior ultrasound probes.

“The optical ultrasound needle is ideal for procedures where there’s a little tissue target that’s difficult to see during keyhole surgery using current methods and missing it might have disastrous effects,” stated Dr Malcolm Finlay, study co-lead and consultant cardiologist at QMUL and Barts Heart Center.

The needle system can emit ultrasound because of the growth and development of a singular composite material composed of the mesh of carbon nanotubes encased in silicone and on the tip from the optical fiber. The pulsed light in the fiber is absorbed through the carbon nanotubes and produces an ultrasound wave because of the photoacoustic effect. Another innovation underpins the recognition from the reflected ultrasound waves at this type of small-scale, the invention of highly sensitive optical fibers incorporating polymer optical microresonators.

The incredibly high-speed from the ultrasound emission and recognition process leads to unparalleled temporal and spatial resolution from the images. The present system can offer live imaging having a resolution as fine as 64 microns, which is one of the width of nine red bloodstream cells. The movement from the heart walls and valves may also be tracked instantly.

Outdoors of cardiology, the imaging system has numerous potential uses in a number of non-invasive procedures, also it even opens-up the potential of advanced applications for example in-womb surgery.

They of researchers behind we’ve got the technology are actually planning towards converting the machine for clinical use within patients.

Open access study in journal Light: Science & Applications: Through-needle all-optical ultrasound imaging in vivo: a preclinical swine study…

Via: College College London…

Toshiba Medical launches new MR means to fix enhance oncology radiotherapy

Printed 30 November 2017

Toshiba Medical, a Canon Group company, features Galan RT Solutions suite of radiotherapy tools, on the premium Vantage Galan 3T MR system.

Galan RT Solutions allow medical service providers to exactly map MR data to PET/CT images to build up confident plans for radiotherapy and prioritize exceptional patient care.

The all-new Galan RT Solutions range from the advanced Universal Couchtop™ MR Overlay from CIVCO Radiotherapy to assist clinicians in precisely figuring out the therapy target area, assisting to improve patient safety by sparing healthy tissue from unnecessary radiation.

The fiberglass and foam couchtop overlay core provides a high amount of stability for that mind, shoulders and neck, and ProdigyTM 2 indexing at 7 cm increments to assist physicians seamlessly transfer from imaging to treatment.

A 3-Pin Lok-Bar offers providers the choice to make use of existing MR-compatible devices by indexing these to the overlay, while adjustable ATLAS body coil technology enables clinicians to mix coils for longer patient coverage that has been enhanced workflow.

Galan RT Solutions are rounded by helping cover their the not compulsory MR Laser from LAP Laser and Mirada RTx Fusion software, which enable providers to attain precise patient marking, accurate planning and exact positioning for effective treatment.

“We are dedicated to offering our customers all the diagnostic imaging tools they have to deliver accurate, confident and efficient patient care,” stated Dominic Cruz, senior director, CT, PET/CT, and MR Sections, Toshiba America Medical Systems, Corporation.

“With Galan RT Solutions on the advanced Vantage Galan 3T system, oncologists can simplify their complex MR exams and develop precise treatment plans to limit radiation dose to precisely where it’s needed.”

Toshiba Medical is showcasing the brand new Galan RT Solutions suite only at that year’s Radiological Society of The United States (RSNA) annual meeting in Chicago, November 26 – December 1, 2017 (Booth #7330, North Hall B).

Toshiba America Medical Systems, a Canon Group company headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment.

Source: Company Pr Release

NTT DATA accelerates adoption of artificial intelligence for medical imaging through partnership with MD.ai

Printed 27 November 2017

NTT DATA Services has announced a partnership with MD.ai, a growing company in imaging research and artificial intelligence (AI) delivery for that clinical imaging space.

Through this partnership, NTT DATA clients now be capable of dive much deeper to their imaging data with algorithms and automation tools which will improve workflow and supply better patient care.

“Artificial intelligence is the main thing on healthcare innovation and customers are constantly requesting new insights and solutions that can result in positive outcomes,” stated Dan Allison, president of healthcare and existence sciences at NTT DATA Services.

 “Therefore, we’ve partnered with MD.ai to assist clients further uncover the need for their data. By utilizing AI for medical imaging, customers may have greater quality of interpretation and greater insights per imaging study to ultimately deliver better healthcare to patients.”

MD.ai brings a distinctive mixture of semi-automated tools for imaging research, collaborative data annotation software, in addition to web-based deployment of algorithms to facilitate AI adoption by healthcare organizations.

 MD.ai’s suite of tools allow people to have fun playing the growth and development of anonymized datasets you can use to validate AI algorithms against labeled studies.

Through participation in NTT DATA Services’ imaging research and advocate AI programs, clients will be part of the revenue stream for studies utilized in validation and also have early use of algorithms for Deep Learning imaging evaluation.

Integration of AI tools in to the workflow of diagnosticians is emerging with several models, including NTT DATA cloud choices with desktop reporting. With MD.ai NTT DATA can operate a subset of algorithms entirely client-side around the desktop, enabling users to dynamically initiate analyses in their workflow.

“We’re excited through the chance to work with NTT DATA, whose executives have proven an image to develop beyond data management into data-driven healthcare,” stated Leon Chen, MD, Chief executive officer at MD.ai.

 “Like a physician, I’m acutely conscious of the outcome AI may have within the clinical space. Through this partnership, we will raise the chance for agile startups and enormous enterprises to get access to large datasets beyond what’s generally currently available. This can greatly accelerate the event and expand the marketplace for AI applications worldwide.”

The 2 companies be onsite in the Radiology Society of The United States (RSNA) Conference November. 26 to 12 ,. one in the NTT DATA Services booth (#1724) to show the advances in AI calibration and delivery tools. MD.ai can also be among the winners within the RSNA 2017 Bone Age Challenge, finishing within the top 5 for showcasing their tools to produce a better dataset for his or her formula.

NTT DATA Services is dedicated to improving patient outcomes by creating efficiencies over the healthcare ecosystem.

An accepted leader within the healthcare space, the organization delivers targeted segment solutions including patient engagement, predictive analytics, healthcare cloud computing, integration and interoperability, clinical and claims application implementation, revenue cycle management and policy administration, additionally to core managed infrastructure, application and business process services.

Its clients include greater than 1,800 hospitals, 2,200 lengthy-term care facilities, 225 acute care facilities, 43,000 clinicians, 1,000 physician practices and 50 insurance firms meant for sixty five million policy owners.

Source: Company Pr Release

Food and drug administration Clearance For Perspectum Diagnostics’ LiverMultiScan™ Means More Patients Can Usually Benefit From Use Of Condition-Of-The-Art Non-Invasive Diagnostic Aid For Liver Disorders

OXFORD, England, November. 27, 2017 /PRNewswire/ — Perspectum Diagnostics Limited, a worldwide leader in the introduction of medical image analysis technologies, announced today in the Radiological Society of The United States (RSNA) conference it has gotten 510(k) clearance in the U.S. Fda (Food and drug administration) for LiverMultiScan™ – a publish-processing software device for magnetic resonance imaging (MRI) from the liver, delivered via a cloud-based service. This latest clearance implies that this excellent technology is now able to utilized on a broader selection of scanners, including compatible Siemens and Philips MR systems, and supply clinicians with standardized, quantitative measures from the liver tissue to help with proper diagnosis of liver disease.

LiverMultiScan enables non-invasive and quantitative liver tissue portrayal to rapidly and precisely evaluate liver fat, in addition to T2* and iron-remedied T1 that are correlates for iron and fibro-inflammatory levels correspondingly. It’s a rapid and scalable technology that may be seamlessly built-into existing MR examinations, without resorting to contrast agent. 

Professor Mukesh Harisinghani, Abdominal Imaging and Interventional Radiologist at Massachusetts General Hospital, remarked, “The introduction of standardized, robust means of quantitative assessment of fatty liver disease is important for patients and physicians. LiverMultiScan is really a helpful radiological tool for clinical practice which will unquestionably slowly move the field forward and facilitate proper care of our patients with liver disease.”

Non-alcoholic fatty liver disease (NAFLD) presently affects greater than 30% of individuals within the U.S. and 10% of individuals within the U.K. If not treated, it can result in cirrhosis and liver failure. NAFLD prevalence is anticipated to improve, driven by rising amounts of weight problems and representing a substantial section of unmet need in global healthcare. This trend is really a growing concern and techniques to avoid, identify and treat NAFLD really are a high priority for health systems.

“Liver disease is a big unmet need,” stated Dr Rajarshi Banerjee, Chief executive officer, Perspectum Diagnostics. “Drug development is hampered by the possible lack of methods to determine effectiveness and outcomes, and to obtain the patients who’d take advantage of the new drugs. MR imaging is really a cornerstone from the diagnostic pathways in neurology, musculoskeletal medicine and cardiology. We are able to now add liver disease for this list, taking us one step further on the journey towards creating a substitute for additional invasive diagnostic approaches for liver disease.”  He adds, “People are in the centre in our innovation. Our studies have proven that using LiverMultiScan leads to help patients visualize their liver condition aids their understanding and engagement within their treatment and care. Once we move towards more patient-centered innovation, we are proud to become leading in this region.Inch

Professor Hildo J. Lamb, Professor of Radiology at Leiden College Clinic, where LiverMultiScan is presently being included in a couple,000-patient multi-center randomized control trial in NAFLD, stated: “Radiology is getting into a brand new era of quantitative imaging. LiverMultiScan supplies a user-friendly platform for MR image acquisition and analysis. Quantitative assessment of fatty liver disease is of vital importance to battle weight problems-related disease.”

More information

About Perspectum Diagnostics 

Perspectum Diagnostics Limited combines the strength of digital imaging technologies and innovative software. We empower patients and also the medical community through greater knowledge of liver disease, enabling earlier diagnosis and targeted treatment.

LiverMultiScan™ is 510(k) removed within the U.S. and CE marked in Europe. LiverMultiScan might not be commercially accessible in most countries. Because of regulatory reasons, its future availability can’t be guaranteed. For more details to learn more, visit http://perspectum-diagnostics.com/.

References

1 Banerjee, R. et al. (2014). Journal Hepatol 60:69–77.
2 Pavlides, M. et al. (2016). J Hepatol, 64:308-315.
3 Pavlides, M. et al. (2017). Multi-parametric magnetic resonance imaging for that assessment of non-alcoholic fatty liver disease severity. Liver Worldwide, 1-9.
4 McKay et al. (2016). Hepatology 64(S1):811-1050

Further history can be obtained at: http://rsna.vporoom.com/PerspectumDiagnostics/index.php?s=35888, including color scan images that may be reproduced (copyright Perspectum Diagnostics Limited).

View original content:http://world wide web.prnewswire.com/news-releases/food and drug administration-clearance-for-perspectum-diagnostics-livermultiscan-means-more-patients-can-benefit-from-access-to-condition-of-the-art-non-invasive-diagnostic-aid-for-liver-disorders-300561597.html

SOURCE Perspectum Diagnostics

Related Links

https://perspectum-diagnostics.com

MedyMatch to show New Clinical Decision Support Platform for Discovering Intracranial Hemorrhage in Acute Care at RSNA 2017

CHICAGO, November. 26, 2017 /PRNewswire/ —

Who:
MedyMatch Chief executive officer Gene Saragnese and also the MedyMatch team.

What:
Demonstrations: MedyMatch Technology, a number one artificial intelligence company delivering real-time clinical decision support in acute medical scenarios, demonstrates deep learning algorithms for that acute care marketplace at RSNA 2017. MedyMatch’s technology is made to work inside the existing workflow to enhance clinicians within their assessment of patients suspected of acute mind trauma or stroke, where intracranial hemorrhage might be present.1

Announcement: MedyMatch may also be creating a major announcement at RSNA 2017.

When:
Sunday, November 26 through Thursday, November 30, 2017 in the Radiological Society of The United States (RSNA) Annual Meeting in Chicago, Illinois.

Where:
The demonstrations will occur within the booths of MedyMatch’s partners – IBM Booth #3337, Samsung Healthcare Booth #2543 and also at the device Learning Showcase Booth #8149 during RSNA 2017 at McCormick Devote Chicago.

Why:
“As the quantity of imaging data to interpret has elevated tremendously, radiologists came under intense pressure for more info cases a lot sooner that is reducing their quality of existence because they find it difficult to be accurate, confident and incredibly, extremely fast,Inch Dr. Ajay Choudhri, Chairman and Medical Director, Department of Radiology, Capital Health Hospital.  “The opportunity to prioritize challenging cases, like a brain hemorrhage, inside the existing workflow, benefits both acute patient in addition to collaborating clinicians.”

Contact:
Michael Rosenberg, [email protected]

1 Pending regulatory approvals.  In america, restricted to Federal Law to investigational use.

View original quite happy with multimedia:http://world wide web.prnewswire.com/news-releases/medymatch-to-demonstrate-new-clinical-decision-support-platform-for-discovering-intracranial-hemorrhage-in-acute-care-at-rsna-2017-300561609.html

SOURCE MedyMatch Technology

Esaote launches MyLab 9 eXP ultrasound system

Printed 24 November 2017

Esaote has launched the MyLab 9 eXP ultrasound system, inside a reaction to the marketplace requirement for a real shared service system with advanced applications.

The MyLab 9 eXP is going to be proven in the Radiology Society of The United States (RSNA), McCormick Place, Booth #3700.

“Ultrasound has been more and more used through the Hospital atmosphere, we have seen a requirement for any highly versatile system that may accomplish a greater diversity of clinical examinations with no compromises that may occur with traditional designs,” states Glenn Davis, President and Gm, of Esaote The United States, Corporation.

Driven through the new Ultra-engine platform, the MyLab 9 eXP offers Ultra-clearness, performance, workflow and cost for that Radiology, Cardiology and Women’s Health clinical segments, both in the non-public practice, clinics and hospital setting. Particularly geared to Rheumatology, Endocrinology, and Prostate imaging.

With unique image optimization and advanced diagnostic tools, and Italian engineering and style, clinicians can rapidly acquire images with Ultra-clearness, color and contrast for elevated diagnostic confidence.

Single very non-composite probe technology provides excellent picture quality. And, Esaote’s appleprobe design, reduces musculoskeletal strain as much as 70% for much better consumer experience and luxury.

Unique image optimization and automation tools – easyMode and easyTrace – increase efficiency and patient throughput, with single touch Automated intelligent Doppler steering and position correction.

Virtual Navigator real-time Fusion is really a fully-integrated multi-modality application that’s touch-screen based on a variety of transducers.

microV+ advanced, fast and never invasive hemodynamic evaluation rich in sensitivity and spatial resolution for lesion portrayal in most clinical applications.

QPack multimodality quantification tool of curve analysis of CnTI CEUS Perfusion in addition to Color and Power Doppler hemodynamics.

Solid-condition hard disk drive (SSD), latest Intel®Core™ i7 processor, and Windows® 10 supporting the most recent data security and processing power needs.

Upgradable, remote service, lengthy-term maintenance options and transducer compatibility result in the MyLab 9 eXP an Ultra-value.

“In everyday clinical practice, it’s crucial more specifically, confident, and fast simultaneously. The easyMode technology from Esaote, enables the operator to conduct the examination having a concentrate on the patient, without distracting all of them with technicalities or complex technical routines from the system.” Carlo Biagini, MD, Radiologist, Florence, Italia.

The MyLab™9 eXP delivers unparalleled precision, power and abilities they are driving well informed healthcare decisions in an excellent value-performance inside a globally connected atmosphere.

Source: Company Pr Release

Nautilus Medical collaborates with Google Cloud for secure radiology storage and image exchange

Nautilus’ simple to use medical information exchange solutions utilize hardware signatures, key strokes, and mouse movements to produce unique private keys that ensures foolproof data security.

The connection between Nautilus and Google will provide more abilities to more sites including underserved professionals in offices that may make use of this effective platform, but don’t possess a plan for more costly choices.

To learn more concerning the new collaboration, come go to Google Cloud booth 8161 in the Radiological Society of The United States (RSNA) annual meeting in Chicago from November 26 to December 1.

Healthcare Tech Outlook lately named Nautilus Medical “Top Ten Medical Imaging Solution Providers – 2017” since Nautilus have a vital effect on medical imaging to save cost, speed of looking after, security and simplicity of use. Nautilus software programs are utilized by greater than 700 sites with a large number of users including 33 from the top 50 medical facilities in america.